(PharmaNewsWire.Com, September 09, 2021 ) According to a new market research "Arthroscopy Instruments Market by Type (Implants, Arthroscope, Visualization System, Surgical Shaver, RF Ablation, Fluid Management), Application (Knee, Hip, Shoulder), End User (Hospitals, Ambulatory Surgery Centers & Clinics) - Global Forecast to 2022", published by MarketsandMarkets™, the global market is projected to reach USD 5.61 Billion by 2022 from 4.17 Billion in 2017, at a CAGR of 6.1% during the forecast period.
Browse in-depth TOC on "Arthroscopy Instruments Market"
The report analyzes and studies the major drivers, restraints, opportunities, and challenges of the Arthroscopy Instruments Market in North America, Europe, Asia Pacific, and the Rest of the World (RoW). The high incidence of sports injuries, growing geriatric population, rising inclination of patients and hospitals towards minimally invasive surgeries, technological advancements in arthroscopy products, and an efficient reimbursement system in developed countries are some of the factors driving the growth of the market.
Based on type, arthroscopic implants segment accounted for the segment of the market in 2017
On the basis of type, the market is segmented into arthroscopic implants, arthroscopes, visualization system, RF ablation system, motorized shavers, and fluid management system. The arthroscopic implants segment is expected to have the largest share in the Arthroscopy Instruments Market in 2017 due to the use of these implants in a majority of arthroscopic surgeries.
The hip, foot, ankle, elbow, and wrist arthroscopy application segment are expected to grow at the highest rate during the forecast period
Based on applications, the Arthroscopy Instruments Market is segmented into knee arthroscopy, shoulder arthroscopy, and other arthroscopy applications. Other arthroscopy applications include hip, foot, ankle, elbow, and wrist arthroscopy. This segment is expected to grow at the fastest CAGR owing to the rising number of hip arthroscopy surgeries and the rising focus of manufacturer towards developing new instruments for complex hip arthroscopy surgeries.
North America accounted for the largest share of the Arthroscopy Instruments Market in 2017
Geographically, the Arthroscopy Instruments Market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. North America accounted for the largest share of the market in 2017, owing to the presence of a large and increasing patient population accompanied by a well-established medical reimbursement policy and initiatives by government & private hospitals expand endoscopy facilities in the region.
The major players of the Arthroscopy Instruments Market are Arthrex (US), Smith & Nephew (UK), DePuy Synthes (US), Stryker (US), Zimmer Biomet (US), CONMED (US), Medtronic (Ireland), Karl Storz (Germany), B. Braun (Germany), Olympus (Japan), Richard Wolf (Germany), MEDICON (Germany), Sklar (US), Millennium (US), and GPC Medical (India).
Browse Related Reports
ENDOSCOPY EQUIPMENT MARKET by Product (Endoscope (Flexible, Rigid, Capsule) Visualization Systems, Endoscopic Ultrasound, Insufflator)), Application (GI Endoscopy, Laparoscopy, Cystoscopy, Bronchoscopy, Colonoscopy, Arthroscopy) - Global Forecast to 2022
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets's flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
